LOS ANGELES, May 20, 2013 /PRNewswire/ -- Today, at the American Psychiatric Association (APA) Meeting in San Francisco, James McGough, M.D., M.S., principal investigator and Professor of Clinical Psychiatry at the Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California Los Angeles (UCLA), and director of clinical teaching programs in both Child and Adolescent Psychopharmacology and ADHD at UCLA, presented the results of a Phase I open-label pediatric clinical trial. The study commenced in November 2011 and investigated the effects of external Trigeminal Nerve Stimulation (eTNS) on Attention Deficit Hyperactivity Disorder (ADHD) as stand-alone monotherapy (i.e., without use of medications of any kind). Mean improvements of over 40% were recorded after 4 weeks and over 45% after 8 weeks (both results pa priori primary outcome metric, the clinician-rated ADHD Rating Scale (ADHD-RS). These results are in line with improvements reported in other clinical trials that used stimulant medications, and form the basis for proceeding with larger clinical trials under double blind conditions to better establish its effects. In the eTNS trial, 20 subjects, aged 7 to 14 years with APA Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of ADHD, had stimulating electric … Continue reading →

Forty-two percent of the children with autism in the enrichment group significantly improved in behaviors such as relating to people and responding to sights and sounds, compared to 7 percent of the standard care group. Olivia Kelly (6) takes a kiss from Buck the therapy dog at the Life Skills/Touch Point Autism Services "Milk and Cookies with Santa" event in Maryland Heights, Missouri on November 27, 2012. UPI/Bill Greenblatt License photo IRVINE, Calif., May 19 (UPI) -- U.S. researchers say autistic boys treated with sensory-motor enrichment showed marked improvement compared to boys receiving traditional treatment. Study co-author Cynthia C. Woo, a project scientist at the University of California, Irvine, said autistic children typically have sensory problems, most common involving smell and touch sensitivity. The six-month study involved 28 autistic boys, ages 3-12. Researchers placed the boys in two groups based on their age and autism severity, with both groups participating in standard behavioral therapy, but boys in one group also undergoing daily environmental -- sensory-motor -- enrichment exercises. Parents of each of the 13 boys in the enrichment group received a kit containing essential oil fragrances such as apple, lavender, lemon and vanilla to stimulate sense of smell. For touch, … Continue reading →

Stroke Care and Treatment- Tuality Healthcare wins the 2013 GoldPlus Award. When a stroke occurs, time equals brain. Dan Friedman who serves as a Neurologist for Tuality Healthcare discusses the warning signs, symptoms and treatment ... By: TualityHealthcare … Continue reading →

Charlotte, NC (PRWEB) May 20, 2013 This May Dr. Charles Payet is using the FDA-cleared laser gum surgery to treat gum disease, which studies have found may increase the risk of stroke. The Laser Assisted New Attachment Procedure uses the Periolase MVP-7, which is the only laser that the FDA has cleared for this procedure. The laser accurately removes bacteria and gum disease. Studies have indicated that good oral hygiene may be beneficial for the entire body, as periodontal disease has been linked to health issues including stroke. Scientists have not determined an exact mechanism, though theories involve bacteria from the mouth entering the bloodstream through the gums. Once in the bloodstream, bacteria may cause inflammation or attach to blockages that are already starting to form in the arteries. When swelling or a clot causes an artery to become completely obstructed, a stroke occurs. Therefore, procedures that improve oral health, such as LANAP, may help reduce the risk of stroke. Dr. Payet begins the LANAP procedure by taking a measurement of the depth of the patients gum pocket. After the laser has removed the bacteria and disease, Dr. Payet uses an ultrasonic tool to take plaque off the surface of … Continue reading →

EuroPCR Presentation of One-Year Data from Robust "Real World" Global Study Demonstrates One of the Lowest Mortality Rates among Similar TAVI Studies PARIS -- May 21, 2013 -- Committed to generating robust clinical data on its CoreValve System for transcatheter aortic valve implantation (TAVI), Medtronic, Inc. (MDT) today unveiled for the first time the complete one-year data from the "real world" Medtronic CoreValve ADVANCE Study. Presented at EuroPCR 2013, the one-year findings from the rigorous study showed low rates of mortality and stroke, along with significant and sustained hemodynamic (blood flow) performance. Consistent with positive one-month clinical outcomes previously reported, the ADVANCE Study demonstrated a low all-cause mortality rate of 17.9 percent, a cardiovascular mortality rate of 11.7 percent, and a very low and stable overall stroke rate of 4.5 percent (minor: 2.3/major: 2.2) at one year. Patients followed to one year also experienced significant and sustained improvements in hemodynamics due to the implanted CoreValve. In addition, patients experienced dramatic symptomatic improvements: while at baseline only 20 percent of patients were classified as NYHA (New York Heart Association) class I or class II, clinical symptoms markedly improved with 85 percent of patients in NYHA class I or II at 30 … Continue reading →